Aim: We aimed to quantify the effects of immune checkpoint inhibitors (ICIs) on the prognosis
of COVID-19. Materials & methods: A meta-analysis was conducted and the hospitalization …

The virus “acute respiratory syndrome coronavirus 2”(SARS-CoV-2) is the etiologic agent of
coronavirus disease 2019 (COVID-19), initially responsible for an outbreak of pneumonia in …

COVID-19 is an RNA virus that attacks the targeting organs, which express angiotensin-
converting enzyme-2 (ACE-2), such as the lungs, heart, renal system, and gastrointestinal …

Purpose: This study examines whether excessive adipose tissue, as measured by the body
mass index (BMI), is associated with higher systemic markers of inflammation and higher …

Acute and chronic lung inflammation is a risk factor for various diseases involving lungs and
extrapulmonary organs. Intercellular and interorgan networks, including crosstalk between …

The cytokine release syndrome or cytokine storm, which is the hyper-induction of
inflammatory responses has a central role in the mortality rate of COVID-19 and some other …

Background: The recently emerged variants of the severe acute respiratory coronavirus 2
(SARS-CoV-2) pose a threat to public health. Understanding the pathogenicity of these …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread around the
world causing a pandemic known as coronavirus disease 2019 (COVID-19). Cytokine storm …

In December 2019, an outbreak of pandemic severe respiratory distress syndrome
coronavirus disease 2019 (COVID-19) initially occurred in China, has spread the world …